Literature DB >> 15530471

EDTA is essential to recover lead from dried blood spots on filter paper.

Maria T Di Martino1, Andzelika Michniewicz, Maria Martucci, Giuseppe Parlato.   

Abstract

BACKGROUND: Residual dried blood spots (DBSs) on filter paper from neonatal screening have been proposed as samples for population survey of lead contamination. We have investigated the EDTA effect on lead release in the eluting solution.
METHODS: Furnace atomic absorption spectrophotometry has been used for lead measurements. Standard, blank and sample solutions contained 2% m/v NH(4)H(2)PO(4), 0.5% v/v Triton X-100 and 0.2% v/v HNO(3) as matrix modifier solution (MMS) with or without EDTA. A calibration curve was established from aqueous standard solutions. Paper discs from DBS and blank, punched near the DBS, were eluted in MM solution and, where required, EDTA at different concentrations. Specimens were leftover DBSs with different storage times, matched samples from 20 adult patients consisting of liquid whole blood (LWB) containing 5 mmol/L EDTA, DBSs eluted in MM solution with 5 mmol/L EDTA or without EDTA.
RESULTS: Optimal lead recovery from DBS required 5 mM EDTA in the eluting solution. Mean lead levels of LWB and DBSs eluted with EDTA were similar and higher than DBSs without EDTA (P<0.001). Without EDTA, the median value of lead optical density was lower for 6-month-old DBSs than for blanks (P<0.001).
CONCLUSIONS: Residual DBSs can be used for population survey, but 5 mmol/L EDTA in the extracting solution is required to fully recover lead.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15530471     DOI: 10.1016/j.cccn.2004.07.019

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  1 in total

1.  Newborn screening archives as a specimen source for epidemiologic studies: feasibility and potential for bias.

Authors:  Susan Searles Nielsen; Beth A Mueller; Anneclaire J De Roos; Harvey Checkoway
Journal:  Ann Epidemiol       Date:  2008-01       Impact factor: 3.797

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.